1. |
Stanescu-Segall D, Balta F, Jackson TL. Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature[J]. Surv Ophthalmol, 2016, 61(1): 18-32. DOI: 10.1016/j.survophthal.2015.04.004.
|
2. |
Cho JH, Ryoo NK, Cho KH, et al. Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2016, 169: 79-88. DOI: 10.1016/j.ajo.2016.06.014.
|
3. |
Scupola A, Coscas G, Soubrane G, et al. Natural history of macular subretinal hemorrhage in age-related macular degeneration[J]. Ophthalmologica, 1999, 213(2): 97-102. DOI: 10.1159/000027400.
|
4. |
Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits[J]. Am J Ophthalmol, 1982, 94(6): 762-773. DOI: 10.1016/0002-9394(82)90301-4.
|
5. |
Vander JF, Federman JL, Greven C, et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration[J]. Ophthalmology, 1991, 98(1): 23-27. DOI: 10.1016/s0161-6420(91)32348-0.
|
6. |
Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: Ⅱ. A surgical approach for age-related macular degeneration?[J]. Graefe's Arch Clin Exp Ophthalmol, 1993, 231(11): 635-641. DOI: 10.1007/BF00921957.
|
7. |
Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration[J]. Am J Ophthalmol, 2006, 142(1): 17-30. DOI: 10.1016/j.ajo.2006.01.090.
|
8. |
Ma Z, Han L, Wang C, et al. Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration[J]. Invest Ophthalmol Vis Sci, 2009, 50(6): 2975-2781. DOI: 10.1167/iovs.08-2573.
|
9. |
van Zeeburg EJ, van Meurs JC. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration[J]. Ophthalmologica, 2013, 229(1): 1-14. DOI: 10.1159/000343066.
|
10. |
Gopalakrishan M, Giridhar A, Bhat S, et al. Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection[J]. Retina, 2007, 27(3): 329-334. DOI: 10.1097/01.iae.0000231544.43093.40.
|
11. |
Shienbaum G, Garcia Filho CA, Flynn HW Jr, et al. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy[J]. Am J Ophthalmol, 2013, 155(6): 1009-1013. DOI: 10.1016/j.ajo.2013.01.012.
|
12. |
Kim JH, Chang YS, Kim JW, et al. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization[J]. Ophthalmology, 2014, 121(4): 926-935. DOI: 10.1016/j.ophtha.2013.11.004.
|
13. |
Hattenbach LO, Klais C, Koch FH, et al. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions[J]. Ophthalmology, 2001, 108(8): 1485-1492. DOI: 10.1016/s0161-6420(01)00648-0.
|
14. |
Olivier S, Chow DR, Packo KH, et al. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration[J]. Ophthalmology, 2004, 111(6): 1201-1208. DOI: 10.1016/j.ophtha.2003.10.020.
|
15. |
Treumer F, Klatt C, Roider J, et al. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage[J]. Br J Ophthalmol, 2010, 94(1): 48-53. DOI: 10.1136/bjo.2009.164707.
|
16. |
Meyer CH, Scholl HP, Eter N, et al. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study[J]. Acta Ophthalmol, 2008, 86(5): 490-494. DOI: 10.1111/j.1600-0420.2007.01125.x.
|
17. |
Kitagawa Y, Shimada H, Mori R, et al. Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy[J]. Ophthalmology, 2016, 123(6): 1278-1286. DOI: 10.1016/j.ophtha.2016.01.035.
|
18. |
Sharma S, Kumar JB, Kim JE, et al. Pneumatic displacement of submacular hemorrhage with subretinal air and tissue plasminogen activator: initial United States experience[J]. Ophthalmol Retina, 2018, 2(3): 180-186. DOI: 10.1016/j.oret.2017.07.012.
|
19. |
徐惠娟, 杨正林. 抗血管内皮生长因子药物治疗渗出型老年性黄斑变性的局限性研究现状[J]. 中华眼底病杂志, 2020, 36(2): 156-161. DOI: 10.3760/cma.j.issn.1005-1015.2020.02.017.Xu HJ, Yang ZL. The limitation of anti-vascular endothelial growth factor treatment for wet age-related macular degeneration[J]. Chin J Ocul Fundus Dis, 2020, 36(2): 156-161. DOI: 10.3760/cma.j.issn.1005-1015.2020.02.017.
|
20. |
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration[J]. N Engl J Med, 2006, 355(14): 1419-1431. DOI: 10.1056/NEJMoa054481.
|
21. |
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular a ge-related macular degeneration[J]. N Engl J Med, 2006, 355(14): 1432-1444. DOI: 10.1056/NEJMoa062655.
|
22. |
de Jong JH, van Zeeburg EJ, Cereda MG, et al. Intravitreal versus subretinal administration of recombinant tissue plasminogen activator combined with gas for acute submacular hemorrhages due to age-related macular degeneration: an exploratory prospective study[J]. Retina, 2016, 36(5): 914-925. DOI: 10.1097/IAE.0000000000000954.
|
23. |
Hillenkamp J, Surguch V, Framme C, et al. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator[J]. Graefe's Arch Clin Exp Ophthalmol, 2010, 248(1): 5-11. DOI: 10.1007/s00417-009-1158-7.
|
24. |
Fassbender JM, Sherman MP, Barr CC, et al. Tissue plasminogen activator for subfoveal hemorrhage due to age-related macular degeneration: comparison of 3 treatment modalities[J]. Retina, 2016, 36(10): 1860-1865. DOI: 10.1097/IAE.0000000000001030.
|
25. |
Shin JY, Lee JM, Byeon SH. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage[J]. Am J Ophthalmol, 2015, 159(5): 904-914. DOI: 10.1016/j.ajo.2015.01.024.
|
26. |
Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits[J]. Am J Ophthalmol, 1999, 128(6): 739-746. DOI: 10.1016/s0002-9394(99)00239-1.
|
27. |
Maggio E, Polito A, Guerriero M, et al. Vitreomacular adhesion and the risk of neovascular age-related macular degeneration[J]. Ophthalmology, 2017, 124(5): 657-666. DOI: 10.1016/j.ophtha.2017.01.018.
|
28. |
陶继伟, 陈亦棋, 毛剑波, 等. 玻璃体黄斑粘连与渗出型老年性黄斑变性相关性的meta分析[J]. 中华眼底病杂志, 2017, 33(6): 626-630. DOI: 10.3760/cma.j.issn.1005-1015.2017.06.017.Tao JW, Chen YQ, Mao JB, et al. The correlation between the vitreomacular adhesion and exudative age-related macular degenerationa meta-analysis[J]. Chin J Ocul Fundus Dis, 2017, 33(6): 626-630. DOI: 10.3760/cma.j.issn.1005-1015.2017.06.017.
|
29. |
Benner JD, Morse LS, Toth CA, et al. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat[J]. Arch Ophthalmol, 1991, 109(12): 1731-1736. DOI: 10.1001/archopht.1991.01080120115039.
|
30. |
Kadonosono K, Arakawa A, Yamane S, et al. Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air[J]. Ophthalmology, 2015, 122(1): 123-128. DOI: 10.1016/j.ophtha.2014.07.027.
|
31. |
姚一民, 马景学, 柴艳霞, 等. 玻璃体腔注射t-PA和SF6治疗外伤性黄斑部视网膜下出血的临床研究[J]. 眼外伤职业眼病杂志, 2010, 31(1): 51-53. DOI: 10.3760/cma.j.issn.2095-1477.2010.03.004.Yao YM, Ma JX, Cai YX, et al. Intravitreous injection of t-PA and GAS of SF6 to treat traumatic hemorrhage of submacular[J]. Chin J Ocul Traum Occupat Eye Dis, 2010, 31(1): 51-53. DOI: 10.3760/cma.j.issn.2095-1477.2010.03.004.
|
32. |
张霜, 张杰, 徐鑫彦, 等. 组织型纤溶酶原激活剂、雷珠单抗联合C3F8治疗息肉样脉络膜血管病变并发早期黄斑下出血的疗效观察[J]. 中华眼底病杂志, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.Zhang S, Zhang J, Xu XY, et al. The efficacy of intravitreal injection of tissue plasminogen activator, ranibizumab and C3F8 in the treatment of early submacular hemorrhage induce to polypoid choroid vasculopathy[J]. Chin J Ocul Fundus Dis, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.
|